Sangamo Therapeutics Inc (NASDAQ:SGMO) currently has a daily average trading volume of 6.95M but it saw 11029947 shares traded in last market. With a market cap of 142.83M USD, the company’s current market price of $0.58 came rising about 13.27 while comparing to the previous closing price of $0.51. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.18 and as low as $0.30. In the recent trading on the day, stock has struck highest price mark of $0.4879 while lowest mark touched by it was $0.5888.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Truist which upgraded the stock as “Buy” in its note to investors issued on December 13, 2024, recommending a price target of $7 for it. RBC Capital Mkts issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $6 and $2.
Over the week, SGMO’s stock price is moving 20.47% up while it is 22.97% when we observe its performance for the past one month. Year-to-date it is 30.85% up and over the past year, the stock is showing a downside performance of -42.94%.
Currently, Sangamo Therapeutics Inc’s total number of outstanding shares is 245.40M with 2.84% of that held by the insiders while 22.34% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -271.09% and return on equity (ROE) at -262.12%. Stock’s beta reads 1.22. Stock has a price to book (P/B) ratio of 26.73 while price to sale or P/S ratio amounts to 2.24. Its return on asset (ROA) is -75.06% on average.
